Co-Diagnostics, Inc.
CODX
$0.34
-$0.01-2.01%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -10.74% | 223.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.74% | 223.86% | |||
| Cost of Revenue | -18.07% | 48.61% | |||
| Gross Profit | -8.94% | 355.75% | |||
| SG&A Expenses | -25.70% | -6.43% | |||
| Depreciation & Amortization | -8.24% | 3.92% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.91% | -4.43% | |||
| Operating Income | 12.96% | 5.78% | |||
| Income Before Tax | 8.61% | -2.61% | |||
| Income Tax Expenses | -9,584.55% | 2.50% | |||
| Earnings from Continuing Operations | 23.85% | -2.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 23.85% | -2.61% | |||
| EBIT | 12.96% | 5.78% | |||
| EBITDA | 13.13% | 6.11% | |||
| EPS Basic | 33.45% | 0.68% | |||
| Normalized Basic EPS | 23.47% | 8.65% | |||
| EPS Diluted | 31.48% | 2.71% | |||
| Normalized Diluted EPS | 23.47% | 8.65% | |||
| Average Basic Shares Outstanding | 14.44% | 3.31% | |||
| Average Diluted Shares Outstanding | 14.44% | 3.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||